🇧🇷 Abreva in Brazil

Abreva (DOCOSANOL) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Abreva in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Dermatology approved in Brazil

Frequently asked questions

Is Abreva approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Abreva in Brazil?

Marketing authorisation holder not available in our data.